Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep;21(9):e70046.
doi: 10.1111/iwj.70046.

A systematic review on the use of transforming powder dressing for wound care

Affiliations

A systematic review on the use of transforming powder dressing for wound care

Madeline J O'Connor et al. Int Wound J. 2024 Sep.

Abstract

The transforming powder dressing (Altrazeal®, Uluru Inc, Addison, TX, USA) is simple to use, painless to apply and has a wear time of up to 30 days. This study aims to review the current literature to elucidate the impact of transforming powder dressing on healing, pain management and overall patient outcomes. We conducted a systematic review following Preferred Reporting Items of Systematic Reviews and Meta-Analyses guidelines. Data including study characteristics, patient demographics and wound outcomes were extracted. Our systematic review included 26 articles (n = 175). Of these articles, 13 (50%) were case reports, 10 (38.5%) were case series, 2 (7.7%) were randomised controlled trials and 1 (3.8%) was a cohort study. Wound types included venous ulcer (23.9%), pressure sore (19.7%), burn (15.5%), skin graft (13.4%), diabetic foot ulcer (4.2%), Mohs defect (3.5%) and other (19.6%). Complete re-epithelialization occurred in 90.1% of the wounds. A total of 19 studies (73%) discussed pain, each of which reported reduced pain with the use of transforming powder dressing. The evaluated studies collectively suggest that transforming powder dressing offers a promising re-epithelialization rate and analgesic effect across various wound types.

Keywords: burns; leg ulcer; pain; pressure sore; wound healing.

PubMed Disclaimer

Conflict of interest statement

Dr. Galiano receives research funding from Altrazeal Life Sciences. All other authors have no competing interests to report.

Figures

FIGURE 1
FIGURE 1
Product image.
FIGURE 2
FIGURE 2
Search strategy.
FIGURE 3
FIGURE 3
Level of evidence pyramid.

References

    1. Fitzgerald RH, Bharara M, Mills JL, Armstrong DG. Use of a Nanoflex powder dressing for wound management following debridement for necrotising fasciitis in the diabetic foot. Int Wound J. 2009;6(2):133‐139. doi: 10.1111/j.1742-481X.2009.00596.x - DOI - PMC - PubMed
    1. Zare M, Bigham A, Zare M, Luo H, Rezvani Ghomi E, Ramakrishna S. pHEMA: an overview for biomedical applications. Int J Mol Sci. 2021;22(12):6376. doi: 10.3390/ijms22126376 - DOI - PMC - PubMed
    1. Wang Y, Chu X, Sun Y, Teng P, Xia T, Chen Y. A convenient approach by using poly‐(HEMA‐co‐NIPAM)/Cu2+ solution sol‐gel transition for wound protection and healing. J Biomed Mater Res B Appl Biomater. 2021;109(1):50‐59. doi: 10.1002/jbm.b.34679 - DOI - PubMed
    1. St John J. Formulation Development and In Vivo Testing of a Novel Powder Wound Dressing Employing Dehydrated Nanoparticle Technology. The University of Texas Southwestern Medical Center at Dallas, Department of Plastic Surgery. 2009.
    1. Altrazeal [Package Insert]. ULURU Inc.; 2017.

Publication types

LinkOut - more resources